GW Pharma Posts CBD Drug for Epilepsy Sales of $86 Million in Q3

New Cannabis Ventures
By NCV NewswireNov 5, 2019, 4:50 pm231 pts
GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Third Quarter Ended September 30, 2019 Epidiolex U.S. year to date net sales of $188.0 million, including Q3 net sales of $86.1 million Conference call today at 4:30 p.m. ET CARLSBAD, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) — GW…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Canadian Cannabis Sales Bounced Further 79

Single Dose Of Psilocybin Provided ‘Rapid Onset’ Relief Of OCD Symptoms, Study Finds 79

Cautious on Canadian Cannabis Companies 77

Cresco Labs becomes latest operator to bail on California weed sector 74

New Survey: 9 in 10 Americans Want Decontaminated Cannabis 73

Oregon Officials Issue Ballot Title For Initiative To Legalize Marijuana Social Lounges 72

California Bill Would Let ‘Small’ Cannabis Producers Ship Directly to Consumers 71

Cannabis rescheduling faces another potential setback 71

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.